Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Judge Rules Against Plavix Recall Based On Sanofi/Bristol’s Settlement Negotiations

This article was originally published in The Pink Sheet Daily

Executive Summary

Provisions included in a Plavix patent infringement settlement agreement between Sanofi-Aventis/Bristol-Myers Squibb and Apotex "foresaw the possibility that Apotex would launch a generic product and prohibited Sanofi from seeking injunctive relief for a specific period of time after the launch occurred," Manhattan Federal Judge Sidney Stein said in an Aug. 31 ruling, refusing to grant a recall of generic clopidogrel
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS064827

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel